# IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.

Study · id `cardio:ct-nct02711098` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02711098](<https://clinicaltrials.gov/study/NCT02711098>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02711098

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

## Technical summary

Registry record NCT02711098. Randomized; single masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-01-14 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 116 participants (enrolled count; ClinicalTrials.gov record NCT02711098, source copy `cardio:ctgov-nct02711098-2019-02-25`, retrieved 2026-10-26)
- Start date: 2016-03 (registry gives no type) (ClinicalTrials.gov record NCT02711098, source copy `cardio:ctgov-nct02711098-2019-02-25`, retrieved 2026-10-26)
- Primary completion: 2018-01-14 (actual) (ClinicalTrials.gov record NCT02711098, source copy `cardio:ctgov-nct02711098-2019-02-25`, retrieved 2026-10-26)
- Completion: 2018-01-14 (actual) (ClinicalTrials.gov record NCT02711098, source copy `cardio:ctgov-nct02711098-2019-02-25`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02711098, source copy `cardio:ctgov-nct02711098-2019-02-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02711098-2019-02-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
- Acronym: IL-HYPERION
- Condition: Cardiac Arrest
- Intervention (Biological): Inflammatory biomarkers dosage "Hypothermia Arm"
- Intervention (Biological): Inflammatory biomarkers dosage "Normothermia Arm"
- Lead sponsor: Centre Hospitalier Departemental Vendee
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Centre Hospitalier Departemental Vendee (`cardio:org-centre-hospitalier-departemental-vendee`)

## Provenance

Content hash: 7f6aee275098ca7da00d815144a9ddfb9eca42aca04208d7389739cf9fb99828
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
